Date of Presentation

5-6-2021 12:00 AM

College

School of Osteopathic Medicine

Poster Abstract

It has been demonstrated that silver oxide coatings designed by our collaborators are able to prevent E. coli and P. aeruginosa attachment to biomaterials in vivo. These findings demonstrate that such coatings show promise in preventing the development of biofilm on biodevices. However, it is unknown if the use of silver oxide in this fashion is toxic in vivo. The goal of this project was to determine whether our silver oxide coatings are safe to use in vivo. To assess the toxicity of our silver oxide formula, mice were implanted with either silver oxide coated titanium discs or uncoated titanium discs. Blood samples were drawn at pre-determined time points in order to determine AST and ALT levels via ELISA assay. Preliminary results demonstrate no acute liver injury after 3 months with the discs. However, it appears as if silver is accumulating in tissues over time. Histological analysis at one year shows evidence of simple steatosis in livers. While our group is continuing to investigate the safety and efficacy of these silver oxides coatings in vivo, preliminary data shows that they may have some toxicity and the silver oxide formula may need to be altered and retested.

Keywords

biofilms, silver oxide, toxicity, biodevices

Disciplines

Animal Experimentation and Research | Biochemistry | Biomedical and Dental Materials | Biotechnology | Laboratory and Basic Science Research | Medicine and Health Sciences | Molecular Biology

Document Type

Poster

Share

COinS
 
May 6th, 12:00 AM

Safety of Silver Oxide Coated Biomaterials in Mice

It has been demonstrated that silver oxide coatings designed by our collaborators are able to prevent E. coli and P. aeruginosa attachment to biomaterials in vivo. These findings demonstrate that such coatings show promise in preventing the development of biofilm on biodevices. However, it is unknown if the use of silver oxide in this fashion is toxic in vivo. The goal of this project was to determine whether our silver oxide coatings are safe to use in vivo. To assess the toxicity of our silver oxide formula, mice were implanted with either silver oxide coated titanium discs or uncoated titanium discs. Blood samples were drawn at pre-determined time points in order to determine AST and ALT levels via ELISA assay. Preliminary results demonstrate no acute liver injury after 3 months with the discs. However, it appears as if silver is accumulating in tissues over time. Histological analysis at one year shows evidence of simple steatosis in livers. While our group is continuing to investigate the safety and efficacy of these silver oxides coatings in vivo, preliminary data shows that they may have some toxicity and the silver oxide formula may need to be altered and retested.

 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.